Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7
The high variability in adherence and patient management in real-world scenarios likely dilutes the potential maximum efficacy seen under controlled clinical trial conditions
An important principle to understand is that the elimination half-life remains constant regardless of dose
Sources: Wessells H, et al
Summary: Berberine is not a GLP-1 receptor agonist and does not bind to or activate GLP-1 receptors like prescription medications such as semaglutide or liraglutide
A school of medical thought supports patients gradually ending their use, but Hong said obesity is generally considered a chronic condition that requires indefinite treatment
Furthermore, regarding the mechanisms of GLP-1 secretion regulation in intestinal L-cells, including the potentiation mechanism of the main pathway, many unresolved aspects remain to be elucidated
.webp)
